Department of Pharmaceutical Sciences, University of Catania, Catania, Italy.
J Neurosci Res. 2011 Apr;89(4):592-600. doi: 10.1002/jnr.22578. Epub 2011 Feb 2.
Anabolic-androgenic steroid (AAS) abuse is associated with multiple neurobehavioral disturbances. The sites of action and the neurobiological sequels of AAS abuse are unclear at present. We investigated whether two different AASs, nandrolone and methandrostenolone, could affect neuronal survival in culture. The endogenous androgenic steroid testosterone was used for comparison. Both testosterone and nandrolone were neurotoxic at micromolar concentrations, and their effects were prevented by blockade of androgen receptors (ARs) with flutamide. Neuronal toxicity developed only over a 48-hr exposure to the steroids. The cell-impermeable analogues testosterone-BSA and nandrolone-BSA, which preferentially target membrane-associated ARs, were also neurotoxic in a time-dependent and flutamide-sensitive manner. Testosterone-BSA and nandrolone-BSA were more potent than their parent compounds, suggesting that membrane-associated ARs were the relevant sites for the neurotoxic actions of the steroids. Unlike testosterone and nandrolone, toxicity by methandrostenolone and methandrostenolone-BSA was insensitive to flutamide, but it was prevented by the glucocorticoid receptor (GR) antagonist RU-486. Methandrostenolone-BSA was more potent than the parent compound, suggesting that its toxicity relied on the preferential activation of putative membrane-associated GRs. Consistently with the evidence that membrane-associated GRs can mediate rapid effects, a brief challenge with methandrostenolone-BSA was able to promote neuronal toxicity. Activation of putative membrane steroid receptors by nontoxic (nanomolar) concentrations of either nandrolone-BSA or methandrostenolone-BSA became sufficient to increase neuronal susceptibility to the apoptotic stimulus provided by β-amyloid (the main culprit of AD). We speculate that AAS abuse might facilitate the onset or progression of neurodegenerative diseases not usually linked to drug abuse.
合成代谢雄激素类固醇(AAS)滥用与多种神经行为障碍有关。目前,AAS 滥用的作用部位和神经生物学后果尚不清楚。我们研究了两种不同的 AAS,诺龙和大力补,是否会影响培养中的神经元存活。内源性雄激素类固醇睾酮被用来作比较。睾酮和诺龙在微摩尔浓度下均具有神经毒性,且其作用可被雄激素受体(AR)阻断剂氟他胺所阻断。类固醇的神经毒性仅在 48 小时的暴露中发展。细胞不可渗透的类似物睾酮-BSA 和诺龙-BSA 也以时间依赖性和氟他胺敏感的方式具有神经毒性。睾酮-BSA 和诺龙-BSA 比它们的母体化合物更有效,这表明膜相关 AR 是类固醇神经毒性作用的相关部位。与睾酮和诺龙不同,大力补和大力补-BSA 的毒性对氟他胺不敏感,但被糖皮质激素受体(GR)拮抗剂 RU-486 所阻断。大力补-BSA 比母体化合物更有效,这表明其毒性依赖于对假定的膜相关 GR 的优先激活。与膜相关 GR 可以介导快速效应的证据一致,短暂的大力补-BSA 挑战能够促进神经元毒性。非毒性(纳摩尔)浓度的诺龙-BSA 或大力补-BSA 对假定的膜甾体受体的激活足以增加神经元对β-淀粉样蛋白(AD 的主要罪魁祸首)提供的凋亡刺激的敏感性。我们推测,AAS 滥用可能会促进通常与药物滥用无关的神经退行性疾病的发生或进展。